Nigerian journal of clinical practice · 2026
The Predictive Value of Early β-hCG Levels After Embryo Transfer in In Vitro Fertilization Treatment.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gürbüz E, Balcı M F, Köse C, Güleç E Ş, Kasap E, Demir A
Аннотация
BACKGROUND: Early serum beta-human chorionic gonadotropin (β-hCG) levels are commonly used to assess pregnancy viability following in vitro fertilization (IVF). However, their predictive value for live birth remains uncertain.
AIM: This study evaluates the predictive value of early β-hCG levels on post-transfer days 12 and 14 in determining live birth outcomes after IVF.
METHODS: A retrospective chart review was conducted on 755 women who underwent IVF between 2017 and 2023. Demographic, clinical, and laboratory data were collected. Serum β-hCG levels were measured on post-transfer days 12 and 14. Receiver operating characteristic (ROC) curve analysis determined optimal β-hCG cutoff values for predicting live birth.
RESULTS: Among participants, 414 (54.8%) achieved live birth. Mean β-hCG levels on day 12 were significantly higher in the live birth group (554.5 ± 378.4 mIU/mL) compared to the non-live birth group (208.0 ± 162.5 mIU/mL, P < 0.001). On day 14, levels remained elevated in live birth cases (1466.8 ± 890.3 mIU/mL vs. 570.0 ± 452.8 mIU/mL, P < 0.001). The rate of β-hCG increase was also greater in the live birth group (P < 0.001). ROC analysis identified cutoffs of 205.5 mIU/mL on day 12 (72.4% sensitivity, 72.3% specificity) and 535 mIU/mL on day 14 (71.4% sensitivity, 71.3% specificity).
CONCLUSION: Early β-hCG levels are strong predictors of live birth following IVF. Establishing clinical thresholds may enhance early pregnancy assessment and patient counseling.
AIM: This study evaluates the predictive value of early β-hCG levels on post-transfer days 12 and 14 in determining live birth outcomes after IVF.
METHODS: A retrospective chart review was conducted on 755 women who underwent IVF between 2017 and 2023. Demographic, clinical, and laboratory data were collected. Serum β-hCG levels were measured on post-transfer days 12 and 14. Receiver operating characteristic (ROC) curve analysis determined optimal β-hCG cutoff values for predicting live birth.
RESULTS: Among participants, 414 (54.8%) achieved live birth. Mean β-hCG levels on day 12 were significantly higher in the live birth group (554.5 ± 378.4 mIU/mL) compared to the non-live birth group (208.0 ± 162.5 mIU/mL, P < 0.001). On day 14, levels remained elevated in live birth cases (1466.8 ± 890.3 mIU/mL vs. 570.0 ± 452.8 mIU/mL, P < 0.001). The rate of β-hCG increase was also greater in the live birth group (P < 0.001). ROC analysis identified cutoffs of 205.5 mIU/mL on day 12 (72.4% sensitivity, 72.3% specificity) and 535 mIU/mL on day 14 (71.4% sensitivity, 71.3% specificity).
CONCLUSION: Early β-hCG levels are strong predictors of live birth following IVF. Establishing clinical thresholds may enhance early pregnancy assessment and patient counseling.